Vaskülitlerin Nörolojik Tutulumu
Özet
Çocukluk çağı vaskülitleri, damar duvarındaki inflamasyon sonucu ortaya çıkan ve çeşitli nörolojik tutulumlara yol açabilen ciddi tablolardır. İgA vasküliti, Kawasaki hastalığı, poliarteritis nodoza, Takayasu arteriti, ANCA ilişkili vaskülitler, Behçet hastalığı ve primer santral sinir sistemi vaskülitleri, farklı klinik seyirleri ve özgün nörolojik belirtileriyle incelenmektedir. Erken tanı ve kişiselleştirilmiş immünsüpresif tedavi stratejileri, ağır nörolojik komplikasyonların önlenmesi ve kalıcı hasar riskinin azaltılması için hayati önem taşımaktadır.
Childhood vasculitides are serious conditions resulting from inflammation of vessel walls that can lead to various neurological manifestations. IgA vasculitis, Kawasaki disease, polyarteritis nodosa, Takayasu arteritis, ANCA-associated vasculitis, Behçet's disease, and primary central nervous system vasculitis are examined through their distinct clinical courses and specific neurological symptoms. Early diagnosis and appropriate immunosuppressive treatment strategies are critical for preventing severe neurological complications and reducing the risk of permanent damage.
Referanslar
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11.
Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33(8):1135-36.
Ozen S, Ruperto N, Dillon MJ, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann rheum Dis 2006;65:936-41.
Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010;69:798-806.
Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch–Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 2002;360:1197-202.
Messberg M, Segelmark M, Kahn R, Englund M, Mohammad AJ. Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden. Sacnd J Rheumatol 2018;47:295-302.
Ozen S, Bakkaloglu A, Dusunsel R, et al. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2007;26:196-200.
Brogan P, Nott KA. Immune complex small-vessel vasculitis. In:Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC (eds). Textbook of Pediatric Rheumatology, 8th ed. Elsevier 2020:456-67.
Pacheva IH, Ivanov IS, Stefanova K, et al. Central Nervous System Involvement in Henoch-Schonlein Purpura in Children and Adolescents. Case Rep Pediatr. 2017;2017:5483543.
Garzoni L, Vanoni F, Rizzi M, et al. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology (Oxford). 2009;48(12):1524-9.
Liu A, Zhang H. Detection of antiphospholipid antibody in children with Henoch-Schönlein purpura and central nervous system involvement. Pediatr Neurol. 2012;47(3):167-70.
Hamano H, Matsushige T, Inoue H, et al. A case of acute encephalophathy with residual neurological sequelae induced by immunoglobulin A vasculitis. J Clin Neurosci. 2019;67:270-1.
Cheni TH. Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Front Pediatr. 2020;8:585.
Lava SA, Peeters GG, Bianchetti MG, Goeggel Simonetti B, Simonetti GD, Milani GP. Posterior reversible encephalopathy syndrome in Henoch-Schönlein purpura. Rheumatol Int. 2017;37(3):461-3.
Liu X, Zhou K, Hua Y, et al. Neurological involvement in Kawasaki disease: a retrospective study. Pediatr Rheumatol Online J. 2020;18(1):61.
Yeom JS, Cho JY, Woo HO. Understanding the importance of cerebrovascular involvement in Kawasaki disease. Korean J Pediatr. 2019;62(9):334-9.
Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun 2014;48-49:84-9.
Ozen S, Anton J, Arisoy N, Bakkaoglu A, Besbas N, Brogan P, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 1992;120:206-9.
Fink, CW. The role of the streptococcus in poststreptococcal reactive arthritis and childhood polyarteritis nodosa. J Rheumatol Suppl 1991;29:14-20.
Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, et al. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology (Oxford) 2020;59(6):1372-80.
Shimojima Y, Ishii W, Kishida D, Fukushima K, Ikeda SI. Imbalanced expression of dysfunctional regulatory T cells and T-helper cells relates to immunopathogenesis in polyarteritis nodosa. Mod Rheumatol. 2017;27(1):102-9.
Ozen, S. The changing face of polyarteritis nodosa and necrotizing vasculitis. Nat Rev Rheumatol 2017;13(6):381-6.
Eleftheriou D, Dillon MJ, Tullus K, et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum. 2013;65(9):2476-85.
Falcini F, La Torre F, Vittadello F, et al. Clinical overview and outcome in a cohort of children with polyarteritis nodosa. Clin Exp Rheumatol. 2014;32(3 Suppl 82):S134-S137.
Mondal R, Sarkar S, Pal P, Nandi M, Hazra A, Sabui TK. Childhood Polyarteritis Nodosa: a prospective multicentre study from eastern India. Indian J Pediatr. 2014;81(4):371-4.
Kasap Cuceoglu M, Sener S, Batu ED, et al. Systematic review of childhood-onset polyarteritis nodosa and DADA2. Semin Arthritis Rheum. 2021;51(3):559-64.
Erden A, Batu ED, Sönmez HE, et al. Comparing polyarteritis nodosa in children and adults: a single center study. Int J Rheum Dis 2017;20(8):1016-22.
Sönmez HE, Armağan B, Ayan G, et al. Polyarteritis nodosa: lessons from 25 years of experience. Clin Exp Rheumatol. 2019;37 Suppl 117(2):52-6.
Iudici M, Quartier P, Pagnoux C, et al. Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group Registry. Autoimmun Rev. 2018;17(10):984-9.
de Boysson H, Guillevin L. Polyarteritis Nodosa Neurologic Manifestations. Neurol Clin. 2019;37(2):345-357. .
Guirola R, Hunter JV, Perez M, Muscal E. Childhood polyarteritis nodosa presenting with central nervous system manifestations and the posterior reversible encephalopathy syndrome. J Child Neurol. 2014;29(1):103-7.
de Graeff N, Groot N, Brogan P, et al. European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. Rheumatology (Oxford). 2019;58(4):656-71.
Brogan PA, Arch B, Hickey H, et al. Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: An open label, randomised, Bayesian, non-inferiority trial. Arthritis Rheumatol. 2021 Mar 24. doi: 10.1002/art.41730. Epub ahead of print.
Conticini E, Sota J, Falsetti P, et al. Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review. Autoimmun Rev. 2021;20(4):102784.
Clemente G, Hilário MO, Len C, et al. Brazilian multicenter study of 71 patients with juvenile-onset Takayasu's arteritis: clinical and angiographic features. Rev Bras Reumatol Engl Ed. 2016;56(2):145-51.
Dammacco F, Cirulli A, Simeone A, et al. Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances. Clin Exp Med. 2021;21(1):49-62.
Goel R, Kumar TS, Danda D, et al. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India. J Rheumatol. 2014;41(6):1183-9.
Szugye HS, Zeft AS, Spalding SJ. Takayasu Arteritis in the pediatric population: a contemporary United States-based single center cohort. Pediatr Rheumatol Online J. 2014;12:21.
Eleftheriou D, Varnier G, Dolezalova P, McMahon AM, Al-Obaidi M, Brogan PA. Takayasu arteritis in childhood: retrospective experience from a tertiary referral centre in the United Kingdom. Arthritis Res Ther. 2015;17(1):36.
Misra DP, Aggarwal A, Lawrence A, Agarwal V, Misra R. Pediatric-onset Takayasu's arteritis: clinical features and short-term outcome. Rheumatol Int. 2015;35(10):1701-6.
Fan L, Zhang H, Cai J, et al. Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients. Arthritis Res Ther. 2019;21(1):31.
Aeschlimann FA, Eng SWM, Sheikh S, et al. Childhood Takayasu arteritis: disease course and response to therapy. Arthritis Res Ther. 2017;19(1):255.
Sahin S, Hopurcuoglu D, Bektas S, et al. Childhood-onset Takayasu arteritis: A 15-year experience from a tertiary referral center. Int J Rheum Dis. 2019;22(1):132-9.
Sönmez HE, Demir F, Özdel S, et al. Neuroimaging of Children With Takayasu Arteritis. J Child Neurol. 2021 Feb 16:883073821991287. doi: 10.1177/0883073821991287. Epub ahead of print.
Porter A, Youngstein T, Tombetti E, Mason JC. Biologic therapy in supra-aortic Takayasu arteritis can improve symptoms of cerebral ischaemia without surgical intervention. Rheumatology (Oxford). 2020;59(Suppl 3):iii28-iii32.
Dai Y, Zhong Y, Jian B, et al. Bridging Therapy for Acute Stroke as the Initial Manifestation of Takayasu Arteritis: A Case Report and Review of Literature. Front Immunol. 2021;12:630619. doi: 10.3389/fimmu.2021.630619.
Aeschlimann FA, Barra L, Alsolaimani R, et al. Presentation and Disease Course of Childhood-Onset Versus Adult-Onset Takayasu Arteritis. Arthritis Rheumatol. 2019;71(2):315-23.
Bolek EC, Kaya Akca U, Sari A, et al. Is Takayasu's arteritis more severe in children? Clin Exp Rheumatol. 2021;39 Suppl 129(2):32-38.
Couture P, Chazal T, Rosso C, et al. Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study. J Neurol. 2018;265(4):757-63.
Clemente G, Pereira RMR, Aikawa N, et al. IS PET/MRI A RELIABLE TOOL FOR DETECTING VASCULAR ACTIVITY IN TREATED CHILDHOOD-ONSET TAKAYASU'S ARTERITIS (C-TA)? A MULTICENTER STUDY. Rheumatology (Oxford). 2021 Mar 15:keab255. doi: 10.1093/rheumatology/keab255. Epub ahead of print.
Batu ED, Sönmez HE, Hazırolan T, Özaltın F, Bilginer Y, Özen S. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature. Semin Arthritis Rheum. 2017;46(4):529-35.
Karabacak M, Kaymaz-Tahra S, Şahin S, et al. Childhood-onset versus adult-onset Takayasu arteritis: A study of 141 patients from Turkey. Semin Arthritis Rheum. 2021;51(1):192-7.
Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094-100.
Sacri AS, Chambaraud T, Ranchin B, et al. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study. Nephrol Dial Transplant. 2015;30 Suppl 1:i104-12.
Cabral DA, Canter DL, Muscal E, et al. Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016;68(10):2514-26.
Morishita KA, Moorthy LN, Lubieniecka JM, et al. Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2017;69(7):1470-9.
Hirano D, Ishikawa T, Inaba A, et al. Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis. Pediatr Nephrol. 2019;34(8):1425-33.
Özçelik G, Sönmez HE, Şahin S, et al. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis. Pediatr Nephrol. 2019;34(5):847-54.
Wang JC, Leader BA, Crane RA, Koch BL, Smith MM, Ishman SL. Granulomatosis with polyangiitis presenting as facial nerve palsy in a teenager. Int J Pediatr Otorhinolaryngol. 2018;107:160-3.
Higuera-Ortiz V, Reynoso A, Ruiz N, Delgado-Hernández RD, Gómez-Garza G, Flores-Suárez LF. Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review. Clin Rheumatol. 2017;36(4):919-24.
Kara O, Demirel F, Acar BC, Cakar N. Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood. J Pediatr Endocrinol Metab. 2013;26(9-10):959-62.
De Luna G, Terrier B, Kaminsky P, et al. Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. Rheumatology (Oxford). 2015;54(3):424-32.
Gendelman S, Zeft A, Spalding SJ. Childhood-onset eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): a contemporary single-center cohort. J Rheumatol. 2013;40(6):929-35.
Eleftheriou D, Gale H, Pilkington C, et al. Eosinophilic granulomatosis with polyangiitis in childhood: retrospective experience from a tertiary referral centre in the UK. Rheumatology (Oxford). 2016;55(7):1263-72.
Fina A, Dubus JC, Tran A, et al. Eosinophilic granulomatosis with polyangiitis in children: Data from the French RespiRare® cohort. Pediatr Pulmonol. 2018;53(12):1640-50.
Andre R, Cottin V, Saraux JL, et al. Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. Autoimmun Rev. 2017;16(9):963-9.
Oiwa H, Mokuda S, Matsubara T, et al. Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA. Intern Med. 2017;56(22):3003-8.
Sharma A, Rajan R, Modi M, et al. Neurological Manifestations Do not Affect Cumulative Survival in Indian Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitis. Neurol India. 2019;67(4):1043-7.
Koné-Paut I, Shahram F, Darce-Bello M, et al. Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958-64.
Gallizzi R, Pidone C, Cantarini L, et al. A national cohort study on pediatric Behçet's disease: cross-sectional data from an Italian registry. Pediatr Rheumatol Online J. 2017;15(1):84.
Demir S, Acari C, Basaran O, et al. Paediatric Behçet's disease with sinus venous thrombosis: experience from three centres in Turkey. Clin Exp Rheumatol. 2019;37 Suppl 121(6):147-51.
Gezgin Yıldırım D, Bakkaloğlu SA, Hasanreisoglu M, Buyan N. Disease activity and outcomes in juvenile Behçet's disease: 10 years' experience of a single centre. Clin Exp Rheumatol. 2020t;38 Suppl 127(5):105-11.
Nanthapisal S, Klein NJ, Ambrose N, Eleftheriou D, Brogan PA. Paediatric Behçet's disease: a UK tertiary centre experience. Clin Rheumatol. 2016;35(10):2509-16.
Çirkinoğlu MS, Demir S, Bilginer Y, Özen S. Behçet’s disease in children: single-center experience. Turk Pediatri Ars 2019;54(3):179-84.
A., Gül. Genetics of Behçet's disease: lessons learned from genomewide association studies. Curr Opin Rheumatol. 2014;26(1):56-63.
Uluduz D, Kürtüncü M, Yapıcı Z, et al. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology. 2011;77(21):1900-5.
Cakar N, Başaran O, Uncu N, et al. Clinical characteristics of paediatric neuro-Behçet's disease: a single tertiary centre experience. Clin Exp Rheumatol. 2014;32(4 Suppl 84):S165-70.
Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A. Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis. 2013;8:18.
Saadoun D, Wechsler B, Resche-Rigon M, et al. Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum. 2009;61(4):518-26.
Akdal G, Yaman A, Men S, et al. Pseudotumor cerebri syndrome without cerebral venous sinus thrombosis in Behçet's disease. J Neurol Sci. 2017;383:99-100.
Uygunoğlu U, Siva A. Behçet's Syndrome and Nervous System Involvement. Curr Neurol Neurosci Rep. 2018;18(7):35.
Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet's syndrome. Ann Rheum Dis. 2018;77(6):808-18.
Calabrese LH, Mallek JA. Primary angiitis of the central nervous system: report of 8 new cases, review of the l,terature, and proposal for diagnostic criteria. Medicine (Baltimore) 1988;67:20–39.
Benseler SM, Silverman E, Aviv RI, et al. Primary central nervous system vasculitis in children. Arthritis Rheum. 2006;54(4):1291-7.
Moharir M, Shroff M, Benseler SM. Childhood central nervous system vasculitis. Neuroimaging Clin N Am. 2013;23(2):293-308.
Benseler SM, deVeber G, Hawkins C, et al. Angiography-negative primary central nervous system vasculitis in children: a newly recognized inflammatory central nervous system disease. Arthritis Rheum. 2005l;52(7):2159-67.
Elbers J, Halliday W, Hawkins C, Hutchinson C, Benseler SM. Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol. 2010;68(5):602-10.
Twilt M, Benseler SM. The spectrum of CNS vasculitis in children and adults. Nat Rev Rheumatol. 2011;8(2):97-107.
Hutchinson C, Elbers J, Halliday W, et al. Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study. Lancet Neurol. 2010;9(11):1078-84.
Quan AS, Brunner J, Rose B, et al. Diagnosis and Treatment of Angiography Positive Medium to Large Vessel Childhood Primary Angiitis of Central Nervous System (p-cPACNS): An International Survey. Front Pediatr. 2021;9:654537.
Beelen J, Benseler SM, Dropol A, Ghali B, Twilt M. Strategies for treatment of childhood primary angiitis of the central nervous system. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e567.
